Literature DB >> 18698674

Chronic liver disease in Aboriginal North Americans.

John D Scott1, Naomi Garland.   

Abstract

A structured literature review was performed to detail the frequency and etiology of chronic liver disease (CLD) in Aboriginal North Americans. CLD affects Aboriginal North Americans disproportionately and is now one of the most common causes of death. Alcoholic liver disease is the leading etiology of CLD, but viral hepatitis, particularly hepatitis C, is an important and growing cause of CLD. High rates of autoimmune hepatitis and primary biliary cirrhosis (PBC) are reported in regions of coastal British Columbia and southeastern Alaska. Non-alcoholic liver disease is a common, but understudied, cause of CLD. Future research should monitor the incidence and etiology of CLD and should be geographically inclusive. In addition, more research is needed on the treatment of hepatitis C virus (HCV) infection and non-alcoholic fatty liver disease (NAFLD) in this population.

Entities:  

Mesh:

Year:  2008        PMID: 18698674      PMCID: PMC2738784          DOI: 10.3748/wjg.14.4607

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  63 in total

Review 1.  Delta hepatitis: an update.

Authors:  Patrizia Farci
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

2.  Canadian mortality rates for liver disease: taking a closer look at ICD coding.

Authors:  Snehal Desai; Kevork M Peltekian
Journal:  Can J Public Health       Date:  2004 May-Jun

3.  Alcoholic cirrhosis among the Navaho.

Authors:  S J Kunitz; J E Levy; M Everett
Journal:  Q J Stud Alcohol       Date:  1969-09

4.  Indications for liver transplantation in British Columbia's Aboriginal population: a 10-year retrospective analysis.

Authors:  E M Yoshida; N R Caron; A K Buczkowski; L T Arbour; C H Scudamore; U P Steinbrecher; S R Erb; S W Chung
Journal:  Can J Gastroenterol       Date:  2000-10       Impact factor: 3.522

5.  Hepatitis C infection and type 2 diabetes in American-Indian women.

Authors:  Charlton Wilson
Journal:  Diabetes Care       Date:  2004-09       Impact factor: 19.112

6.  Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001.

Authors:  Stephanie R Bialek; Douglas A Thoroughman; Diana Hu; Edgar P Simard; Jody Chattin; Jim Cheek; Beth P Bell
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

7.  Hepatitis and hepatitis B-antigen in Greenland. II: Occurrence and interrelation of hepatitis B associated surface, core, and "e" antigen-antibody systems in a highly endemic area.

Authors:  P Skinhoj
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

8.  Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus.

Authors:  B J McMahon; T R Bender; K R Berquist; M T Schreeder; A P Harpster
Journal:  J Clin Microbiol       Date:  1981-08       Impact factor: 5.948

9.  Chronic liver disease mortality in the United States, 1990-1998.

Authors:  Sirenda Vong; Beth P Bell
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

10.  Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.

Authors:  Andrew J Muir; Jeffrey D Bornstein; Paul G Killenberg
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

View more
  9 in total

1.  Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009.

Authors:  Anil Suryaprasad; Kathy K Byrd; John T Redd; David G Perdue; M Michele Manos; Brian J McMahon
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

2.  Addressing Hepatitis C within a Southwest Tribal Community.

Authors:  Francine C Gachupin; Rene Harbaugh; Alex Amarillas; Frances Cupis; Jason Lockwood; Shanna J Tautolo
Journal:  Ethn Dis       Date:  2018-10-18       Impact factor: 1.847

3.  Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians.

Authors:  Matthew T Haren; Ming Li; John Petkov; Robyn A McDermott
Journal:  BMC Public Health       Date:  2010-08-03       Impact factor: 3.295

Review 4.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

5.  Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study.

Authors:  Abdullah Ghassan Muhammad; Frederik Orm Hansen; Rasmus Hvidbjerg Gantzel; Karsten Fleischer Rex; Gerda Elisabeth Villadsen; Henning Grønbæk; Michael Lynge Pedersen
Journal:  Int J Circumpolar Health       Date:  2022-12       Impact factor: 1.941

6.  Adult idiopathic cholestasis: a condition more common in the Canadian Inuit?

Authors:  Gerald Y Minuk; Galia Pollock; Julia Uhanova
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

Review 7.  Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.

Authors:  Julia D Rempel; Julia Uhanova
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

8.  Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley.

Authors:  Muhammad Y Sheikh; Pradeep R Atla; Adnan Ameer; Humaira Sadiq; Patrick C Sadler
Journal:  Gut Liver       Date:  2012-12-14       Impact factor: 4.519

9.  Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal.

Authors:  Parmvir Parmar; Daniel J Corsi; Curtis Cooper
Journal:  Can J Gastroenterol Hepatol       Date:  2016-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.